NCT06105424View on ClinicalTrials.gov

BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 24, 2016

Primary Completion Date

December 28, 2016

Study Completion Date

December 28, 2016

Conditions
Tobacco UseSmokingSmoking, Tobacco
Interventions
PROCEDURE

Lung Permeability Assessment

A gamma camera will be used to scintigraphically monitor the clearance of an inhaled radiolabeled tracer molecule from the lungs into the blood. Clearance will be monitored for 60 minutes. The rate of clearance of radioactivity will serve as an index of alveolar epithelial permeability.

Trial Locations (1)

68502

Celerion, Inc., Lincoln

All Listed Sponsors
lead

RAI Services Company

INDUSTRY

NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability | Biotech Hunter | Biotech Hunter